Home / Recalls / Precision Dose Inc. / D-0741-2026

D-0741-2026 Class II Ongoing

Recalled by Precision Dose Inc. — South Beloit, IL

FDA drug recall D-0741-2026 was initiated by Precision Dose Inc. on July 14, 2026 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing. Affected quantity: N/A.

Recall Details

Product Type: Drugs
Report Date: July 29, 2026
Initiation Date: July 14, 2026
Termination Date: N/A
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: N/A

Product Description

Glycopyrrolate Oral Solution, 1 mg/5 mL, delivers 5 mL, Rx only, Pkg: Precision Dose, Inc, S. Beloil, IL 61080, unit-dose oral syringes, NDCs 68094-073-01 (oral syringe) and 68094-073-58 (case).

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution Pattern

US Nationwide.

Code Information

Lot # 506033, Exp Date: 11/30/2026.

Other recalls by Precision Dose Inc.

D-0094-2022 Class II — Acetaminophen Oral Suspension, 160 mg/5 mL, packaged in 5 mL per cup (NDC Indivi (November 1, 2021)
D-0095-2022 Class II — Acetaminophen Oral Suspension, 325 mg/10.15 mL, packaged in 10.15 mL per cup (N (November 1, 2021)
D-0228-2021 Class II — Chlorhexidine Gluconate Oral Rinse USP 0.12%, packaged in a) 15 mL x 30 Unit Dos (January 1, 2021)
D-1004-2020 Class II — Ranitidine Oral Solution, USP, 150 mg/10 mL, [10 mL x 30 Unit Dose Cups per case (November 13, 2019)
D-0057-2018 Class III — Carbamazepine Oral Suspension USP, 100 mg/5 mL, 5 mL Unit Dose Cups (NDC 68094-3 (September 25, 2017)
D-1037-2017 Class II — Carbamazepine Oral Suspension, USP. 100 mg/5 mL, 5 mL Unit Dose Cups, Rx Only, P (July 5, 2017)
D-250-2013 Class II — Children's Acetaminophen Oral Suspension, 650 mg/20.3 mL unit dose cup (NDC 6809 (March 21, 2013)